Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Thomas

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Breast Cancer Research : BCR|July 10, 2010
Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapyJohn M S Bartlett, Jeremy Thomas, Douglas T Ross, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2015
Addressing overtreatment of screen detected DCIS; the LORIS trialAdele Francis, Jeremy Thomas, Lesley Fallowfield, et al.
Annals of Surgical Oncology|November 30, 2017
Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) TrialDaniel Rea, Adele Francis, Matthew Wallis, et al.
The Lancet. Oncology|May 16, 2015
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trialHelena M Earl, Louise Hiller, Janet A Dunn, et al.
Nature|December 7, 2021
Multi-omic machine learning predictor of breast cancer therapy responseStephen-John Sammut, Mireia Crispin-Ortuzar, Suet-Feung Chin, et al.
Oncotarget|April 25, 2015
FKBPL: a marker of good prognosis in breast cancerLaura Nelson, Hayley D McKeen, Andrea Marshall, et al.
The Western Journal of Emergency Medicine|August 12, 2025
Letter of Concern from the Association of Academic Chairs of Emergency Medicine Regarding ACGME Proposed ChangesRichard J Hamilton, Lance B Becker, Richard E Wolfe, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Breast Cancer Research : BCR|July 10, 2010
Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapyJohn M S Bartlett, Jeremy Thomas, Douglas T Ross, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2015
Addressing overtreatment of screen detected DCIS; the LORIS trialAdele Francis, Jeremy Thomas, Lesley Fallowfield, et al.
Annals of Surgical Oncology|November 30, 2017
Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) TrialDaniel Rea, Adele Francis, Matthew Wallis, et al.
The Lancet. Oncology|May 16, 2015
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trialHelena M Earl, Louise Hiller, Janet A Dunn, et al.
Nature|December 7, 2021
Multi-omic machine learning predictor of breast cancer therapy responseStephen-John Sammut, Mireia Crispin-Ortuzar, Suet-Feung Chin, et al.
Oncotarget|April 25, 2015
FKBPL: a marker of good prognosis in breast cancerLaura Nelson, Hayley D McKeen, Andrea Marshall, et al.
The Western Journal of Emergency Medicine|August 12, 2025
Letter of Concern from the Association of Academic Chairs of Emergency Medicine Regarding ACGME Proposed ChangesRichard J Hamilton, Lance B Becker, Richard E Wolfe, et al.
Pageof 8